GlassScriptPhysician profile
Julie A Bauer
NPI 1326011925
$11,300.99
in general payments reported to CMS, 2019-2025
45 companies · $2,414 in 2025
The $2,414 reported for 2025 was more than what 80% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,594 · 2020: $2,403 · 2021: $44.33 · 2022: $174 · 2023: $786 · 2024: $1,885 · 2025: $2,414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,053 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,053.26 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $4,793.52 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Novo Nordisk INC | $1,295.93 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Sanofi-Aventis U.S. LLC | $455.99 | 2019-2025 | |
| Beta Bionics, INC. | $392.34 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Cequr Corporation | $388.83 | 2023-2025 | Cequr Simplicity |
| Lilly USA, LLC | $351.83 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $336.65 | 2019-2020 | |
| Amgen INC. | $332.80 | 2019-2025 | Tepezza, Evenity, Prolia |
| Radius Health, INC. | $242.92 | 2019-2025 | |
| Amneal Pharmaceuticals LLC | $241.22 | 2019-2025 | Unithroid |
| Abbvie INC. | $230.78 | 2019-2025 | Synthroid |
| Dexcom, INC. | $200.23 | 2019-2025 | Dexcom G6 Transmitter |
| Ibsa Pharma INC. | $142.60 | 2021-2025 | Tirosint, Tirosint, Licart |
| Boehringer Ingelheim Pharmaceuticals, INC. | $136.19 | 2019-2025 | Jardiance, Synjardy |
| Janssen Pharmaceuticals, INC | $129.75 | 2019-2020 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Bauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.